blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1828171

EP1828171 - HETEROCYCLE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  16.01.2015
Database last updated on 14.06.2024
Most recent event   Tooltip08.07.2016Lapse of the patent in a contracting state
New state(s): HU
published on 10.08.2016  [2016/32]
Applicant(s)For all designated states
MSD Italia S.r.l.
Via Vitorchiano, 151
00189 Rome / IT
[2014/21]
Former [2007/36]For all designated states
ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A.
Via Pontina Km. 30.600
00040 Pomezia / IT
Inventor(s)01 / Attenni, Barbara
IRBM
Via Pontina Km 30.600
I-00040 Pomezia / IT
02 / Ferrigno, Federica
IRBM
Via Pontina Km 30.600
I-00040 Pomezia / IT
03 / JONES, Philip
Via Pontina KM 30.600
I-00040 Pomezia / IT
04 / Ingenito, Raffaele
IRBM
Via Pontina Km 30.600
I-00040 Pomezia / IT
05 / Kinzel, Olaf
IRBM
Via Pontina Km 30.600
I-00040 Pomezia / IT
06 / Llauger Bufi, Laura
IRBM
Via Pontina Km 30.600
I-00040 Pomezia / IT
07 / Ontoria Ontoria, Jesus Maria
IRBM
Via Pontina Km 30.600
I-00040 Pomezia / IT
08 / Pescatore, Giovanna
IRBM
Via Pontina Km 30.600
I-00040 Pomezia / IT
09 / Rowley, Michael
IRBM
Via Pontina Km 30.600
I-00040 Pomezia / IT
10 / Scarpelli, Rita
IRBM
Via Pontina Km 30.600
I-00040 Pomezia / IT
11 / Schultz, Carsten
IRBM
Via Pontina Km 30.600
I-00040 Pomezia / IT
 [2014/11]
Former [2007/36]01 / Attenni, Barbara
IRBM, Via Pontina Km 30.600
I-00040 Pomezia / IT
02 / Ferrigno, Federica
IRBM, Via Pontina Km 30.600
I-00040 Pomezia / IT
03 / JONES, Philip
Via Pontina KM 30.600
I-00040 Pomezia / IT
04 / Ingenito, Raffaele
IRBM, Via Pontina Km 30.600
I-00040 Pomezia / IT
05 / Kinzel, Olaf
IRBM, Via Pontina Km 30.600
I-00040 Pomezia / IT
06 / Llauger Bufi, Laura
IRBM, Via Pontina Km 30.600
I-00040 Pomezia / IT
07 / Ontoria Ontoria, Jesus Maria
IRBM, Via Pontina Km 30.600
I-00040 Pomezia / IT
08 / Pescatore, Giovanna
IRBM, Via Pontina Km 30.600
I-00040 Pomezia / IT
09 / Rowley, Michael
IRBM, Via Pontina Km 30.600
I-00040 Pomezia / IT
10 / Scarpelli, Rita
IRBM, Via Pontina Km 30.600
I-00040 Pomezia / IT
11 / Schultz, Carsten
IRBM, Via Pontina Km 30.600
I-00040 Pomezia / IT
Representative(s)Horgan, James Michael Frederic, et al
Merck Sharp & Dohme Corp.
120 Moorgate
London, EC2M 6UR / GB
[N/P]
Former [2014/11]Horgan, James Michael Frederic, et al
Merck & Co., Inc. European Patent Department Hertford Road Hoddesdon
EN11 9BU / GB
Former [2007/36]Horgan, James Michael Frederic, et al
Merck & Co., Inc. European Patent Department Hertford Road Hoddesdon
Hertfordshire EN11 9BU / GB
Application number, filing date05818301.309.12.2005
[2007/36]
WO2005GB04743
Priority number, dateGB2004002713810.12.2004         Original published format: GB 0427138
GB2005001643511.08.2005         Original published format: GB 0516435
[2007/36]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2006061638
Date:15.06.2006
Language:EN
[2006/24]
Type: A2 Application without search report 
No.:EP1828171
Date:05.09.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 15.06.2006 takes the place of the publication of the European patent application.
[2007/36]
Type: B1 Patent specification 
No.:EP1828171
Date:12.03.2014
Language:EN
[2014/11]
Search report(s)International search report - published on:EP03.08.2006
ClassificationIPC:C07D405/12
[2013/08]
CPC:
C07D405/12 (EP,US); A61P1/04 (EP); A61P1/16 (EP);
A61P11/00 (EP); A61P11/06 (EP); A61P13/12 (EP);
A61P17/00 (EP); A61P17/02 (EP); A61P17/06 (EP);
A61P19/00 (EP); A61P19/02 (EP); A61P21/04 (EP);
A61P25/00 (EP); A61P25/14 (EP); A61P25/16 (EP);
A61P25/18 (EP); A61P25/28 (EP); A61P27/02 (EP);
A61P29/00 (EP); A61P3/10 (EP); A61P31/00 (EP);
A61P31/04 (EP); A61P31/12 (EP); A61P33/00 (EP);
A61P35/00 (EP); A61P35/02 (EP); A61P37/02 (EP);
A61P37/06 (EP); A61P37/08 (EP); A61P43/00 (EP);
A61P5/00 (EP); A61P5/14 (EP); A61P5/38 (EP);
A61P7/06 (EP); A61P9/00 (EP); A61P9/04 (EP);
A61P9/08 (EP); A61P9/10 (EP); A61P9/14 (EP);
C07D231/10 (EP,US); C07D403/12 (EP,US); C07D413/12 (EP,US);
C07D417/12 (EP,US) (-)
Former IPC [2007/36]C07D403/12, C07D413/12, C07D231/10, A61K31/405, C07D417/12, A61P37/06, C07D407/12
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/36]
TitleGerman:HETEROZYKLISCHE DERIVATE ALS HISTONDEACETYLASE-INHIBITOREN[2007/36]
English:HETEROCYCLE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS[2007/36]
French:DERIVES HETEROCYCLIQUES UTILISES COMME INHIBITEURS D'HISTONE DESACETYLASE (HDAC)[2007/36]
Entry into regional phase10.07.2007National basic fee paid 
10.07.2007Designation fee(s) paid 
10.07.2007Examination fee paid 
Examination procedure10.07.2007Examination requested  [2007/36]
29.10.2007Despatch of a communication from the examining division (Time limit: M06)
06.05.2008Reply to a communication from the examining division
01.06.2010Despatch of a communication from the examining division (Time limit: M06)
13.12.2010Reply to a communication from the examining division
28.02.2013Communication of intention to grant the patent
05.07.2013Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
27.09.2013Communication of intention to grant the patent
24.01.2014Fee for grant paid
24.01.2014Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  29.10.2007
Opposition(s)15.12.2014No opposition filed within time limit [2015/08]
Fees paidRenewal fee
02.01.2008Renewal fee patent year 03
05.01.2009Renewal fee patent year 04
04.01.2010Renewal fee patent year 05
03.01.2011Renewal fee patent year 06
06.12.2011Renewal fee patent year 07
07.12.2012Renewal fee patent year 08
06.12.2013Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU09.12.2005
AT12.03.2014
BE12.03.2014
CY12.03.2014
CZ12.03.2014
DK12.03.2014
EE12.03.2014
FI12.03.2014
LT12.03.2014
LV12.03.2014
MC12.03.2014
PL12.03.2014
RO12.03.2014
SE12.03.2014
SI12.03.2014
SK12.03.2014
BG12.06.2014
GR13.06.2014
IS12.07.2014
PT14.07.2014
IE09.12.2014
LU09.12.2014
[2016/32]
Former [2016/28]AT12.03.2014
BE12.03.2014
CY12.03.2014
CZ12.03.2014
DK12.03.2014
EE12.03.2014
FI12.03.2014
LT12.03.2014
LV12.03.2014
MC12.03.2014
PL12.03.2014
RO12.03.2014
SE12.03.2014
SI12.03.2014
SK12.03.2014
BG12.06.2014
GR13.06.2014
IS12.07.2014
PT14.07.2014
IE09.12.2014
LU09.12.2014
Former [2016/27]AT12.03.2014
BE12.03.2014
CY12.03.2014
CZ12.03.2014
DK12.03.2014
EE12.03.2014
FI12.03.2014
LT12.03.2014
LV12.03.2014
MC12.03.2014
PL12.03.2014
RO12.03.2014
SE12.03.2014
SI12.03.2014
SK12.03.2014
BG12.06.2014
IS12.07.2014
PT14.07.2014
IE09.12.2014
LU09.12.2014
Former [2015/46]AT12.03.2014
BE12.03.2014
CY12.03.2014
CZ12.03.2014
DK12.03.2014
EE12.03.2014
FI12.03.2014
LT12.03.2014
LV12.03.2014
PL12.03.2014
RO12.03.2014
SE12.03.2014
SI12.03.2014
SK12.03.2014
BG12.06.2014
IS12.07.2014
PT14.07.2014
IE09.12.2014
LU09.12.2014
Former [2015/36]AT12.03.2014
BE12.03.2014
CY12.03.2014
CZ12.03.2014
DK12.03.2014
EE12.03.2014
FI12.03.2014
LT12.03.2014
LV12.03.2014
PL12.03.2014
RO12.03.2014
SE12.03.2014
SI12.03.2014
SK12.03.2014
BG12.06.2014
IS12.07.2014
PT14.07.2014
LU09.12.2014
Former [2015/35]AT12.03.2014
BE12.03.2014
CY12.03.2014
CZ12.03.2014
DK12.03.2014
EE12.03.2014
FI12.03.2014
LT12.03.2014
LV12.03.2014
PL12.03.2014
RO12.03.2014
SE12.03.2014
SK12.03.2014
BG12.06.2014
IS12.07.2014
PT14.07.2014
LU09.12.2014
Former [2015/08]AT12.03.2014
BE12.03.2014
CY12.03.2014
CZ12.03.2014
DK12.03.2014
EE12.03.2014
FI12.03.2014
LT12.03.2014
LV12.03.2014
PL12.03.2014
RO12.03.2014
SE12.03.2014
SK12.03.2014
BG12.06.2014
IS12.07.2014
PT14.07.2014
Former [2015/02]AT12.03.2014
BE12.03.2014
CY12.03.2014
CZ12.03.2014
EE12.03.2014
FI12.03.2014
LT12.03.2014
LV12.03.2014
PL12.03.2014
RO12.03.2014
SE12.03.2014
SK12.03.2014
BG12.06.2014
IS12.07.2014
PT14.07.2014
Former [2014/51]AT12.03.2014
BE12.03.2014
CY12.03.2014
CZ12.03.2014
EE12.03.2014
FI12.03.2014
LT12.03.2014
LV12.03.2014
PL12.03.2014
RO12.03.2014
SE12.03.2014
SK12.03.2014
BG12.06.2014
IS12.07.2014
Former [2014/50]BE12.03.2014
CY12.03.2014
CZ12.03.2014
EE12.03.2014
FI12.03.2014
LT12.03.2014
LV12.03.2014
PL12.03.2014
RO12.03.2014
SE12.03.2014
SK12.03.2014
BG12.06.2014
IS12.07.2014
Former [2014/49]BE12.03.2014
CY12.03.2014
CZ12.03.2014
EE12.03.2014
FI12.03.2014
LT12.03.2014
LV12.03.2014
RO12.03.2014
SE12.03.2014
BG12.06.2014
IS12.07.2014
Former [2014/48]BE12.03.2014
CY12.03.2014
CZ12.03.2014
EE12.03.2014
FI12.03.2014
LT12.03.2014
LV12.03.2014
SE12.03.2014
BG12.06.2014
Former [2014/46]BE12.03.2014
CY12.03.2014
FI12.03.2014
LT12.03.2014
LV12.03.2014
SE12.03.2014
Former [2014/41]CY12.03.2014
FI12.03.2014
LT12.03.2014
LV12.03.2014
SE12.03.2014
Former [2014/37]CY12.03.2014
FI12.03.2014
LT12.03.2014
SE12.03.2014
Former [2014/36]LT12.03.2014
Cited inInternational search[DX]WO9964401  (SOD CONSEILS RECH APPLIC [FR], et al) [DX] 1-13 * claim 1 *;
 [XD]WO0210140  (SOD CONSEILS RECH APPLIC [FR], et al) [XD] 1-13 * claim 1 *;
 [DA]WO2004072047  (FUJISAWA PHARMACEUTICAL CO [JP], et al) [DA] 1-13* claim 1 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.